JAMA Intern Med 173:534539 Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC (2011) Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
The second is semaglutide, a GLP-1 receptor agonist that researchers already know from Wegovy and Ozempic
No causal relationship between tirzepatide and thyroid cancer has been established in humans
GLP-1 medications amplify this effect pharmacologically making it easier to eat less, feel satisfied sooner, and maintain a calorie deficit without relying entirely on willpower
Pregnancy and Breastfeeding Status Doctors check whether the patient is pregnant, planning pregnancy, or breastfeeding, as use may not be recommended in such cases